Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Amyris Inc
AMRSQ
Chemicals
Specialty Chemicals
Amyris, Inc. is a synthetic biotechnology company. The component of the Company is derived from marketing and selling Clean Beauty, Personal Care, and Health & Wellness consumer products through its direct-to-consumer e-commerce platforms and a growing network of retail partners. The Company’s sustainable ingredients are sold in bulk to industrial leaders who serve Flavor & Fragrance (F&F...
), Nutrition, Food & Beverage, and Clean Beauty & Personal Care end markets. The ingredients and consumer products it produces by its Lab-to-Market technology platform. The Company leverages machine learning, robotics, and artificial intelligence, which enables its technology platform to rapidly bring new market at commercial scale. The Lab-to-Market technology platform utilizes optimized and automated molecular biology, analytical, and process development tools combined with machine learning algorithms and statistical models to transform the way microbes metabolize sugars.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:AMRSQ)
New Post
View:
Posts & Comments
Threaded Posts
(4)
•••
AviseAnalytics
X
View Profile
View Bullboard History
Post by
AviseAnalytics
on Mar 30, 2023 9:16am
AMYRIS: REINVENTING THE BEAUTY AND PERSONAL CARE INDUSTRY
$AMRS We are excited to share an article about Amyris Inc. (NASDAQ: AMRX), a synthetic biotechnology company known for its innovative Lab-to-Market technology platform and clean beauty
...more
(31)
•••
jthottam
X
View Profile
View Bullboard History
Post by
jthottam
on Feb 03, 2022 7:42pm
New SeekingAlpha Article:"Amyris:Surviving the Perfect Storm
New comprehensive and forward-looking article just published on SeekingAlpha https://seekingalpha.com/.../4484181-amyris-surviving... Hope you enjoy it as much as I did. Happy Investing!
(31)
•••
jthottam
X
View Profile
View Bullboard History
Post by
jthottam
on Dec 22, 2021 4:52pm
Answer to a Yahoo Question on AMRS Share Price
I thought this would be helpful for everyone but is in response to Jan R.'s question about "I need AMRS to reach $25 to become a millionaire. Will this happen one day? Yay or Nay?"
...more
(31)
•••
jthottam
X
View Profile
View Bullboard History
Post by
jthottam
on Dec 20, 2021 11:36pm
Update from ImmunityBio (includes information on AMRS JV)
Update: Amyris (Ticker: AMRS) The following press release today (December 20th, 2021) from ImmunityBio (Ticker: IBRX) discusses some of their recent progress in their pharmaceutical
...more
(31)
•••
jthottam
X
View Profile
View Bullboard History
Post by
jthottam
on Dec 18, 2021 2:12am
IDRI Contract with BARDA (potential opportunity for AMRS)
Update: Amyris (Ticker: AMRS) The following was published by Infection Disease Research Institue ("IDRI") whom AMRS has an exclusive license for an RNA vaccine platform.
...more
(31)
•••
jthottam
X
View Profile
View Bullboard History
Post by
jthottam
on Dec 16, 2021 7:05pm
Status Update on IBRX and AMRS
The following is a recent CNN video of an interview of the Chairman of ImmunityBio (Ticker: IBRX) Patrick Soon-Shiong who is in a joint venture with AMRS for developing a 2nd generation vaccine that
...more
(31)
•••
jthottam
X
View Profile
View Bullboard History
Post by
jthottam
on Dec 13, 2021 1:06am
My thoughts on Q4 Revenue Forecast
UPDATE: Amyris (Ticker: AMRS) My Q4 forecast estimates: From the Q3 call, we know that AMRS revenues were impacted due to supply chain disruptions as follows
...more
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Sep 26, 2021 7:33pm
Rare Cannabinoid Manufacturing Market
A market set to explode to $10B sales by 2025. Amyris is making them and so is InMed. We're just getting started. This paints a picture of what's going on: https://youtu.be/i7nlfnWlpPs
(4)
•••
LandCruiser1983
X
View Profile
View Bullboard History
Comment by
LandCruiser1983
on Jan 04, 2021 12:49pm
RE:RE:Great day
And again today, up 13%
(4)
•••
LandCruiser1983
X
View Profile
View Bullboard History
Comment by
LandCruiser1983
on Dec 30, 2020 6:05pm
RE:Great day
And repeat again today
(4)
•••
LandCruiser1983
X
View Profile
View Bullboard History
Post by
LandCruiser1983
on May 29, 2020 4:40pm
Great day
To the moon.
(79)
•••
coolfooldumbguy
X
View Profile
View Bullboard History
Post by
coolfooldumbguy
on Feb 14, 2020 11:48am
the technical chart is strong and
showing a steady uptrend for the springtime,so glta shareholders.
(79)
•••
coolfooldumbguy
X
View Profile
View Bullboard History
Post by
coolfooldumbguy
on Feb 14, 2020 11:41am
still holding this stock
it looks like a breakout to the upside,so glta shareholders.
(79)
•••
coolfooldumbguy
X
View Profile
View Bullboard History
Post by
coolfooldumbguy
on Feb 11, 2020 3:17pm
it's a buy today for me
at these low prices,chance to make a double here,so glta shareholders.
(0)
•••
sept14
X
View Profile
View Bullboard History
Post by
sept14
on Apr 11, 2019 11:12am
shack-out or what ?
that $2.58 really look good, For now,we'll keep a eye on it. N
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >